Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry
Blue light cystoscopy (BLC) using hexaminolevulinate (HAL/Cysview/Hexvix) has been previously shown to improve detection of non –muscle-invasive bladder cancer (NMIBC). Herein, we evaluated the detection of malignant lesions in a heterogenous group of patients in the real world setting and documented the change in risk category due to upstaging or upgrading.
Source: Urologic Oncology: Seminars and Original Investigations - Category: Urology & Nephrology Authors: Siamak Daneshmand, Soroush T. Bazargani, Trinity J. Bivalacqua, Jeffrey M. Holzbeierlein, Brian Willard, Jennifer M. Taylor, Joseph C. Liao, Kamal Pohar, James Tierney, Badrinath Konety, Blue Light Cystoscopy with Cysview Registry Group Tags: Original article Source Type: research